Related Experiment Video

Updated: Aug 26, 2026

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
09:24

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Published on: June 14, 2016

Airway management in mucopolysaccharide storage disorders

Shai Y Shinhar1, Hedy Zablocki, David N Madgy

  • 1Department of Pediatric Otolaryngology, Children's Hospital of Michigan, Detroit 48201, USA. shinhar1@yahoo.com

Archives of Otolaryngology--Head & Neck Surgery
|February 18, 2004
PubMed

Insights

Mucopolysaccharidoses (MPS) present unique airway challenges for otolaryngologists. Managing these genetic disorders requires individualized airway strategies, from intubation to tracheostomy, to address respiratory compromise.

Area of Science:

  • Otolaryngology
  • Genetics
  • Pediatric Respiratory Medicine

Background:

  • Mucopolysaccharidoses (MPS) are rare genetic disorders.
  • MPS involves abnormal mucopolysaccharide deposition, impacting various tissues.
  • Airway complications are a significant concern in MPS patients.

Observation:

  • This study presents 3 pediatric cases of MPS with progressive respiratory embarrassment.
  • Patients required specialized airway management interventions.
  • Erratic mucopolysaccharide deposits in the trachea complicate airway stenting decisions.

Findings:

  • Effective airway management in MPS necessitates a tailored, case-by-case approach.
  • Interventions ranged from intubation to tracheostomy tube placement.
  • Understanding the pathophysiology of MPS is crucial for successful airway management.

Implications:

  • Otolaryngologists must consider MPS-specific airway challenges.
  • Customized airway solutions are vital for patient safety and outcomes.
  • Further research into MPS airway management techniques is warranted.

More Related Videos

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation